The European Union's pharmaceutical sector is in a ongoing state of progression. With stringent regulations, increasing patient expectations, and the accelerated pace of research, navigating this challenging landscape requires a tactical approach. Pharmaceutical companies must adjust to this challenges by adopting cutting-edge technologies, partner